Medicare Enrolled

Dr. Banafsheh Yafeh, M.D.

Vascular Neurology Physician · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
701 E 28TH ST, Long Beach, CA 90806
5624263656
In practice since 2007 (18 years)
NPI: 1760677892 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yafeh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yafeh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yafeh

Dr. Banafsheh Yafeh is a vascular neurology physician in Long Beach, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Yafeh performed 1,391 Medicare services across 577 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yafeh received a total of $16,084 from 71 pharmaceutical and/or device companies across 784 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yafeh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 8% volume in CA $16,084 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,391
Medicare services
Top 8% in CA for vascular neurology physician
577
Unique beneficiaries
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
685 $100 $139
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
216 $177 $350
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
150 $149 $246
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
103 $145 $330
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $97 $175
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
58 $47 $150
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
47 $78 $150
New patient office visit, complex (60-74 min) 38 $188 $338
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,084
Total received (2018-2024)
Avg $2,298/year across 7 years
Top 15% in CA for vascular neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
784
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,833 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$251 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,913
2023
$3,012
2022
$3,056
2021
$3,274
2020
$1,676
2019
$1,777
2018
$1,374

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$292
ABBVIE INC.
$259
Celgene Corporation
$162
Alexion Pharmaceuticals, Inc.
$162
Amgen Inc.
$132
UCB, Inc.
$114
Biogen, Inc.
$109
Neurocrine Biosciences, Inc.
$93
PFIZER INC.
$79
Eisai Inc.
$64
Lundbeck LLC
$54
EMD Serono, Inc.
$52
SK Life Science, Inc.
$49
Abbott Laboratories
$47
MITSUBISHI TANABE PHARMA AMERICA, INC.
$40
ARGENX US, INC.
$39
CSL Behring
$36
Genentech USA, Inc.
$35
ACADIA Pharmaceuticals Inc
$30
Kyowa Kirin, Inc.
$24
SCILEX PHARMACEUTICALS INC.
$23
Lilly USA, LLC
$19
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,878
Biogen, Inc.
$846
UCB, Inc.
$810
Neurocrine Biosciences, Inc.
$793
Alexion Pharmaceuticals, Inc.
$745
AbbVie Inc.
$735
Teva Pharmaceuticals USA, Inc.
$734
ABBVIE INC.
$580
Amgen Inc.
$579
CSL Behring
$560
ACADIA Pharmaceuticals Inc
$448
SK Life Science, Inc.
$429
Lilly USA, LLC
$416
Sunovion Pharmaceuticals Inc.
$372
GENZYME CORPORATION
$355
EMD Serono, Inc.
$350
Lundbeck LLC
$349
Celgene Corporation
$335
AstraZeneca Pharmaceuticals LP
$329
Allergan, Inc.
$321
Kyowa Kirin, Inc.
$272
Genentech USA, Inc.
$218
US WorldMeds, LLC
$193
Biohaven Pharmaceuticals, Inc.
$180
PFIZER INC.
$178
Adamas Pharmaceuticals, Inc.
$166
Takeda Pharmaceuticals U.S.A., Inc.
$164
Horizon Therapeutics plc
$164
Biohaven Pharmaceutical Holding Company Ltd.
$157
Supernus Pharmaceuticals, Inc.
$156
Upsher-Smith Laboratories LLC
$151
Jazz Pharmaceuticals Inc.
$150
Sumitomo Pharma America, Inc.
$144
Janssen Pharmaceuticals, Inc
$121
Alnylam Pharmaceuticals Inc.
$107
ARGENX US, INC.
$106
MDD US Operations, LLC
$106
Neurelis, Inc.
$105
Grifols USA, LLC
$101
Eisai Inc.
$89
Avanir Pharmaceuticals, Inc.
$87
MITSUBISHI TANABE PHARMA AMERICA, INC.
$80
Acorda Therapeutics, Inc
$80
GE HEALTHCARE
$59
Mallinckrodt Enterprises LLC
$56
Vanda Pharmaceuticals Inc.
$55
Allergan Inc.
$52
Amylyx Pharmaceuticals, Inc.
$51
Mallinckrodt Hospital Products Inc.
$49
Abbott Laboratories
$47
LivaNova USA, Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Greenwich Biosciences, Inc.
$33
UPSHER-SMITH LABORATORIES LLC
$28
Catalyst Pharmaceuticals, Inc.
$27
EISAI INC.
$26
NOVARTIS PHARMACEUTICALS CORPORATION
$23
SCILEX PHARMACEUTICALS INC.
$23
SANOFI-AVENTIS U.S. LLC
$23
ARBOR PHARMACEUTICALS, INC.
$23
Chiesi USA, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
AQUESTIVE THERAPEUTICS, INC.
$21
Strongbridge US INC.
$20
Ipsen Biopharmaceuticals, Inc
$18
Boston Scientific Corporation
$17
IDORSIA PHARMACEUTICALS US INC
$17
LeMaitre Vascular, Inc.
$16
Impax Laboratories, Inc.
$15
Mylan Pharmaceuticals Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$12
Top 3 companies account for 22.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANASTOCLIP · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BOTOX · BRILINTA · Briviact · CLEVIPREX · COPAXONE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · RYTARY · Rebif · SOLIRIS · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Vimpat · XADAGO · XARELTO · XCOPRI · XIFAXAN · Xadago · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a vascular neurology physician in Long Beach?
Compare vascular neurology physicians in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse vascular neurology physicians nearby

Geographic Context

Vascular neurology physicians within 10 mi
23
Per 100K population
0.2
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yafeh is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yafeh experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Yafeh performed 685 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yafeh receive payments from pharmaceutical companies?
Yes. Dr. Yafeh received a total of $16,084 from 71 companies across 784 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yafeh's costs compare to other vascular neurology physicians in Long Beach?
Dr. Yafeh's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yafeh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →